Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy
Tiejun Shui, Chao Shi, Zhichun Jing, Degang Yang, Jianyu Zhu
American Journal of Tropical Medicine and Hygiene · 2020-08
Abstract
Rifampicin is a highly effective antibacterial drug and an important component of multidrug therapy used to treat leprosy. Side effects of rifampicin are rare with the once-a-month dosage regimen of anti-leprosy multidrug therapy. Here, we report a case of rifampicin-induced thrombocytopenia during anti-leprosy treatment. Although rare, this potential side effect merits attention.
MeSH terms
- Rifampicin
- Leprosy
- Medicine
- Lepromatous leprosy
- Dapsone
- Pharmacotherapy
- Dermatology
- Regimen
- Antibiotics
- Tuberculosis
- Internal medicine
- Surgery
- Pharmacology
- Immunology